EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.3.2.24 | Adenocarcinoma of Lung |
33734107 |
UBE2V2 Positively Correlates With PD-L1 Expression and Confers Poor Patient Survival in Lung Adenocarcinoma. |
causal interaction
diagnostic usage
unassigned |
3
4
0 |
| 2.3.2.24 | Anemia |
28774900 |
UBE2O remodels the proteome during terminal erythroid differentiation. |
causal interaction
unassigned |
4
0 |
| 2.3.2.24 | Autoimmune Diseases |
34279042 |
Variants on the UBE2L3-YDJC autoimmune disease risk haplotype increase UBE2L3 gene expression by modulating CTCF and YY1 binding. |
causal interaction
unassigned |
2
0 |
| 2.3.2.24 | Breast Neoplasms |
31907353 |
UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPK?2/mTORC1-MYC positive feedback loop. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
1 |
| 2.3.2.24 | Carcinogenesis |
28162974 |
A UBE2O-AMPK?2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
3
4
0 |
| 2.3.2.24 | Carcinogenesis |
28616582 |
A new duet in cancer biology: AMPK the typical and UBE2O the atypical. |
causal interaction
therapeutic application
unassigned |
2
1
0 |
| 2.3.2.24 | Carcinogenesis |
31907353 |
UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPK?2/mTORC1-MYC positive feedback loop. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
1 |
| 2.3.2.24 | Carcinogenesis |
32901121 |
UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 2.3.2.24 | Carcinoma |
19083192 |
The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma. |
causal interaction
ongoing research
unassigned |
3
3
0 |
| 2.3.2.24 | Carcinoma |
21281817 |
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma. |
causal interaction
ongoing research
unassigned |
4
3
0 |
